Budesonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q3OKS62Q6X. European Medicines Agency schedules Budesonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05955MIG. Budesonide generally arises in the molecular formula C25H34O6. The term BUDESONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17.) BUDESONIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule budesonide under HS 29372900 and SITC 54153. As of Q4 2014, BUDESONIDE remains the US FDA Preferred Term for this commodity. Budesonide bears US NLM identifiers UMLS ID C0054201 and NCI Concept Code C1027. SMILES: CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C.